Showing results (681-690 of 697) with videos related to

Sort By:
Pageof 70
Journal of Computer Assisted Tomography|April 16, 2024
Imaging of Neuroendocrine Neoplasms; Principles of Treatment Strategies. What Referring Clinicians Want to KnowLuigi Asmundo, Valentina Ambrosini, Amirkasra Mojtahed, et al.
Nephron|February 11, 2025
CHA2DS2-VASc Score as a Predictor of Cardiovascular and All-Cause Mortality in a Prospective Cohort of Hemodialysis Patients of Predominantly African Ancestry: The PROHEMOGabriel Brayan Gutiérrez-Peredo, Andrea Jimena Gutiérrez-Peredo, Iris Montaño-Castellón, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|September 8, 2000
Intermittent doxercalciferol (1alpha-hydroxyvitamin D(2)) therapy for secondary hyperparathyroidismJ M Frazão, L Elangovan, H M Maung, et al.
BMC Nephrology|November 22, 2024
The urine protein/creatinine ratio as a reliable indicator of 24-h urine protein excretion across different levels of renal function and proteinuria: the TUNARI prospective studyGabriel Brayan Gutiérrez-Peredo, Iris Montaño-Castellón, Andrea Jimena Gutiérrez-Peredo, et al.
Haematologica|November 30, 2019
Specialized pro-resolving lipid mediators are differentially altered in peripheral blood of patients with multiple sclerosis and attenuate monocyte and blood-brain barrier dysfunctionGijs Kooij, Claudio Derada Troletti, Alessandro Leuti, et al.
Seminars in Dialysis|April 20, 2017
Renal Replacement Therapy and Incremental Hemodialysis for Veterans with Advanced Chronic Kidney DiseaseKamyar Kalantar-Zadeh, Susan T Crowley, Srinivasan Beddhu, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|March 3, 2001
Efficacy and side effects of intermittent intravenous and oral doxercalciferol (1alpha-hydroxyvitamin D(2)) in dialysis patients with secondary hyperparathyroidism: a sequential comparisonH M Maung, L Elangovan, J M Frazão, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 25, 2018
Specific oxylipins enhance vertebrate hematopoiesis via the receptor GPR132Jamie L Lahvic, Michelle Ammerman, Pulin Li, et al.
JCI Insight|June 28, 2016
Distal vessel stiffening is an early and pivotal mechanobiological regulator of vascular remodeling and pulmonary hypertensionFei Liu, Christina Mallarino Haeger, Paul B Dieffenbach, et al.
Science Immunology|April 26, 2024
Up-regulated PLA2G10 in cancer impairs T cell infiltration to dampen immunityTianxiang Zhang, Weiwei Yu, Xiaoxiao Cheng, et al.
Pageof 70